Percutaneous Puncture Surgery Robot Market Report 2026

Percutaneous Puncture Surgery Robot Market Overview

• Percutaneous Puncture Surgery Robot market size has reached to $1.98 billion in 2025 • Expected to grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Increasing Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Shorter Recovery Times, Reducing Complications, And Enhancing Patient Safety • Market Trend: Innovative Robotic Solutions Enhance Precision In Minimally Invasive Vascular Procedures • North America was the largest region in 2025 and Asia-pacific is the fastest growing region.

What Is Covered Under Percutaneous Puncture Surgery Robot Market?

A percutaneous puncture surgery robot is a medical robotic system designed to assist surgeons in performing minimally invasive procedures by precisely guiding needles or instruments through the skin to target internal tissues or organs. It enhances accuracy, reduces human error, and minimizes patient trauma compared to traditional manual puncture techniques. The main types of percutaneous puncture surgery robot are prostate puncture robots, lung puncture robots, kidney puncture robots, and pancreas puncture robots. A prostate puncture robot is a specialized medical robotic system designed to assist surgeons in accurately guiding needles or instruments for minimally invasive procedures, such as biopsies or therapies, within the prostate gland. Based on surgical type, it is categorized into robot-assisted percutaneous surgery and traditional percutaneous surgery, and it integrates advanced technologies such as robotic-assisted navigation, augmented reality, and artificial intelligence and machine learning. It is applied across multiple surgical fields, including orthopedic surgery, cardiovascular surgery, neurological surgery, urological surgery, and general surgery and caters to various end users such as hospitals, ambulatory surgical centers, and specialized clinics.

What Is The Percutaneous Puncture Surgery Robot Market Growth Forecast?

The percutaneous puncture surgery robot market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to adoption of ai-guided surgical systems, expansion in hospital and ambulatory surgical centers, integration of augmented reality with robotics, innovations in percutaneous puncture procedures, partnerships between robot manufacturers and healthcare providers. Major trends in the forecast period include robotic-assisted percutaneous surgery, augmented reality navigation systems, ai-guided needle placement, minimally invasive surgical robotics, integration with imaging modalities.

Global Percutaneous Puncture Surgery Robot Market Segmentation

1) By Type: Prostate Puncture Robot, Lung Puncture Robot, Kidney Puncture Robot 2) By Technology: Robotic Needle Guidance and Navigation, Artificial Intelligence–Enabled Target Planning, Motion Compensation and Respiratory Tracking, Image Fusion and 3D Targeting Software 3) By Clinical Application: Urology (Prostate Biopsy, Renal Procedures), Pulmonology (Lung Biopsy, Lung Ablation Access), Oncology (Tumor Biopsy and Localized Interventions), Interventional Radiology, Nephrology 4) By End User: Hospitals, Specialized Interventional Clinics, Diagnostic and Imaging Centers Subsegments: 1) By Prostate Puncture Robot: Transperineal Prostate Puncture, Transrectal Prostate Puncture 2) By Lung: Computed Tomography Guided Lung Puncture, Ultrasound Guided Lung Puncture 3) By Kidney: Percutaneous Nephrolithotomy Puncture, Renal Biopsy Puncture

What Is The Driver Of The Percutaneous Puncture Surgery Robot Market?

The increasing demand for minimally invasive procedures is expected to propel the growth of the percutaneous puncture surgery robot market going forward. Minimally invasive procedures refer to medical interventions performed through small incisions or openings, reducing patient trauma and recovery time. The demand for minimally invasive surgical procedures is increasing due to their ability to offer shorter recovery times, reduced risks of complications, less pain, and smaller scars, making them more appealing to patients seeking quicker and safer treatment options. Percutaneous Puncture Surgery Robot enhances minimally invasive procedures by providing precise needle guidance, making them ideal for tumor ablations and biopsies. They reduce surgical errors by offering accurate, real-time navigation, improving patient safety and procedural efficiency. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the minimally invasive procedures grew 7% in 2023, exceeding the growth of conventional surgical procedures by 2%. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the percutaneous puncture surgery robot industry.

Key Players In The Global Percutaneous Puncture Surgery Robot Market

Major companies operating in the percutaneous puncture surgery robot market are Intuitive Surgical Inc., Quantum Surgical SAS, iSYS Medizintechnik GmbH, Perfint Healthcare Private Limited, MicroPort Corporation, Robocath S.A.S., XACT Robotics Inc., NDR Medical Technology, Yuanhua Technology Co. Ltd., BEC Medical, Perlove Medical, Biobot Surgical Pte Ltd, Veran Medical Technologies Inc., Clear Guide Medical, Aimooe Technology Co. Ltd., Renishaw plc, Zimmer Biomet Holdings Inc., Perfexion Robotics, NeuroPuncture Systems, Synaptive Medical

Global Percutaneous Puncture Surgery Robot Market Trends and Insights

Major companies operating in the percutaneous puncture surgery robot market are focusing on developing innovative solutions, such as vascular intervention surgical robots, to enhance precision, reduce complications, and improve patient recovery. Vascular intervention surgical robots are robotic systems designed to assist surgeons in performing minimally invasive procedures on blood vessels, such as navigating catheters and guidewires with high precision and control. For instance, in December 2023, Robocath S.A.S., a France-based MedTech company, partnered with Microport Medical B.V., a China-based medical devices company, and received market approval from the National Medical Products Administration (NMPA) for the R-ONE vascular intervention surgical robot. This vascular intervention surgical robot is designed to assist interventional cardiologists in performing precise, minimally invasive procedures such as percutaneous coronary interventions (PCI) by improving control, enhancing safety, and reducing radiation exposure. The robot incorporates advanced dual-finger grasp mimic technology, allowing continuous 0 to 360-degree rotation and precise, hand-like manipulation for superior handling of complex and tortuous vascular lesions. Additionally, the system significantly minimizes radiation exposure to both patients and operators through optimized robotic navigation and reduced reliance on fluoroscopy.

What Are Latest Mergers And Acquisitions In The Percutaneous Puncture Surgery Robot Market?

In February 2025, Toulouse University Hospital (CHU), a France-based public university hospital, acquired the Epione robotic platform from Quantum Surgical SAS for an undisclosed amount. With this acquisition, Toulouse University Hospital aims to advance minimally invasive, precision cancer treatments and improve patient outcomes through cutting-edge robotic technology. Quantum Surgical SAS is a France-based medical robotics company that provides percutaneous puncture surgery robots.

Regional Outlook

North America was the largest region in the percutaneous puncture surgery robot market in 2025. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Percutaneous Puncture Surgery Robot Market?

The percutaneous puncture surgery robot market consists of revenues earned by entities by providing services such as surgical planning and simulation services, maintenance and technical support, remote surgery and teleoperation support, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous puncture surgery robot market also includes sales of robotic arm systems, 3D imaging and navigation systems, needle insertion modules, endoscopic camera systems, computer-aided planning software, and haptic feedback systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.